Top

Gepubliceerd in:

07-03-2023 | Review

Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review

Auteurs: Faryal Zahir, Alicia Hanman, Nazmehr Yazdani, Sabrina La Rosa, Gemma Sleik, Brooke Sullivan, Ava Mehdipour, Selina Malouka, Ayse Kuspinar

Gepubliceerd in: Quality of Life Research | Uitgave 9/2023

Abstract

Purpose

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. There are many patient-reported outcome measures (PROMs) for measuring quality of life (QoL) and health-related QoL (HRQoL) within this population; however, there is limited consensus regarding which are most valid, reliable, responsive, and interpretable. This systematic review assesses the psychometric properties and interpretability of QoL and HRQoL PROMs for individuals with ALS.

Methods

This review was conducted following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) methodology for systematic reviews of PROMs. MEDLINE, EMBASE, and CINAHL databases were searched. Studies were included if their aim was to evaluate one or more psychometric properties or the interpretability of QoL or HRQoL PROMs in individuals with ALS.

Results

We screened 2713 abstracts, reviewed 60 full-text articles, and included 37 articles. Fifteen PROMs were evaluated including generic HRQoL (e.g., SF-36), ALS-specific HRQoL (e.g., ALSAQ-40), and individualized QoL (e.g., SEIQoL) measures. Evidence for internal consistency and test–retest reliability were acceptable. For convergent validity, 84% of hypotheses were met. For known-groups validity, outcomes were able to distinguish between healthy cohorts and other conditions. Responsiveness results ranged from low to high correlations with other measures over 3–24 months. Evidence for content validity, structural validity, measurement error, and divergent validity was limited.

Conclusion

This review identified evidence in support of the ALSAQ-40 or ALSAQ-5 for individuals with ALS. These findings can guide healthcare practitioners when selecting evidence-based QoL and HRQoL PROMs for patients and provide researchers with insight into gaps in the literature.

vorige artikel Patient-reported outcomes and patient-reported outcome measures in liver transplantation: a scoping review

volgende artikel China Health Related Outcomes Measures (CHROME): development of a descriptive system to support cardiovascular disease specific preference-based measure for the Chinese population

Alleen toegankelijk voor geautoriseerde gebruikers

van Es, M. A., Hardiman, O., Chio, A., Al-Chalabi, A., Pasterkamp, R. J., Veldink, J. H., & van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. Lancet, 390(10107), 2084–2098.PubMed

Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017). Amyotrophic lateral sclerosis. Nature Reviews. Disease Primers, 3, 17085.PubMed

Gladman, M., & Zinman, L. (2015). The economic impact of amyotrophic lateral sclerosis: A systematic review. Expert Review of Pharmacoeconomics & Outcomes Research, 15(3), 439–450.

Longinetti, E., & Fang, F. (2019). Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Current Opinion in Neurology, 32(5), 771–776.PubMedPubMedCentral

Talbott, E. O., Malek, A. M., & Lacomis, D. (2016). The epidemiology of amyotrophic lateral sclerosis. Handbook of Clinical Neurology, 138, 225–238.PubMed

Hogden, A. (2014). Optimizing patient autonomy in amyotrophic lateral sclerosis: Inclusive decision-making in multidisciplinary care. Neurodegenerative Disease Management, 4(1), 1–3.PubMed

Jenkinson, C., Fitzpatrick, R., & Jenkinson, D. (2000). Health status measurement in neurological disorders. Radcliffe Medical Press.

Simmons, Z. (2015). Patient-perceived outcomes and quality of life in ALS. Neurotherapeutics, 12(2), 394–402.PubMed

Gopalakrishnan, S., & Ganeshkumar, P. (2013). Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare. J Family Med Prim Care, 2(1), 9–14.PubMedPubMedCentral

10.

Lidwine, B., Mokkink, C. A. P., Donald, L. P., Jordi, A., Lex, M. B., de Vet Henrica, C. W., Caroline, B. T. (2018). COSMIN manual for systematic reviews of PROMs COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs) user manual, pp. 1–78.

11.

Terwee, C. B., Jansma, E. P., Riphagen, I. I., & de Vet, H. C. (2009). Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Quality of Life Research, 18(8), 1115–1123.PubMedPubMedCentral

12.

Mokkink, L. B., de Vet, H. C. W., Prinsen, C. A. C., Patrick, D. L., Alonso, J., Bouter, L. M., & Terwee, C. B. (2018). COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27(5), 1171–1179.PubMed

13.

de Vet, H. C., Terwee, C. B., Mokkink, L. B., & Knol, D. L. (2011). Measurement in medicine: A practical guide. Cambridge Universtiy Press.

14.

Deeks, J. J. (2011). Chapter 9: Analysing data and undertaking meta-analyses. In Cochrane handbook for systematic reviews of interventions version 5.1.0.

15.

Schünemann, H. B. J., Guyatt, G., & Oxman, A. (2013). GRADE handbook for grading quality of evidence and strength of recommendations. In H. Schünemann, J. Brożek, G. Guyatt & A. Oxman (Eds.).

16.

Alankaya, N., Tulek, Z., Ozakgul, A., Kaya, A., & Dik, A. (2019). Validity and reliability of the Turkish version of the amyotrophic lateral sclerosis assessment questionnaire. The Journal of Neuroscience Nursing, 51(5), 253–258.PubMed

17.

Gayoso, M. V., Domingues, F. S., de Barros, G. A. M., Franca Junior, M. C., Felgoise, S. H., & Oliveira, A. S. B. (2020). Cross-cultural adaptation and validation for the Brazilian population of the instrument amyotrophic lateral sclerosis-specific quality of life-short form (ALSSQOL-SF). Quality of Life Research, 29(3), 805–813.PubMed

18.

Peters, N., Dal Bello-Haas, V., Packham, T., Chum, M., O’Connell, C., Johnston, W. S., MacDermid, J. C., Turnbull, J., Van Damme, J., & Kuspinar, A. (2021). Do generic preference-based measures accurately capture areas of health-related quality of life important to individuals with amyotrophic lateral sclerosis: A content validation study. Patient related outcome measures, 12(101551170), 191–203.PubMedPubMedCentral

19.

De Marchi, F., Berry, J. D., Caldwell, S., Ellrodt, A., Scalia, J., Burke, K., Fang, T., Chan, J., Clark Sisodia, R., Schwamm, L. H., Moura, L. M. V. R., & Paganoni, S. (2020). Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. Journal of Neurology, 267(6), 1754–1759.PubMed

20.

McColl, E., Shaw, P. J., Gibson, G. J., & Bourke, S. C. (2004). Validation of quality of life instruments in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5(1), 55–60.PubMed

21.

Neudert, C., Wasner, M., & Borasio, G. D. (2004). Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. Journal of Palliative Medicine, 7(4), 551–557.PubMed

22.

Clarke, S., Hickey, A., O’Boyle, C., & Hardiman, O. (2001). Assessing individual quality of life in amyotrophic lateral sclerosis. Quality of Life Research, 10(2), 149–158.PubMed

23.

Neudert, C., Wasner, M., & Borasio, G. D. (2001). Patients’ assessment of quality of life instruments: A randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191(1–2), 103–109.PubMed

24.

Tramonti, F., Bongioanni, P., Di Bernardo, C., Davitti, S., & Rossi, B. (2012). Quality of life of patients with amyotrophic lateral sclerosis. Psychology, Health & Medicine, 17(5), 621–628.

25.

Forshew, D. A., & Bromberg, M. B. (2002). Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology, 58(2), 320–322.PubMed

26.

Felgoise, S. H., Stewart, J. L., Bremer, B. A., Walsh, S. M., Bromberg, M. B., & Simmons, Z. (2009). The SEIQoL-DW for assessing quality of life in ALS: Strengths and limitations. Amyotrophic Lateral Sclerosis, 10(5–6), 456–462.PubMed

27.

Jakobsson Larsson, B., Ozanne, A. G., Nordin, K., & Nygren, I. (2017). A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta neurologica Scandinavica, 136(6), 631–638.PubMed

28.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, n71.

29.

Hong, G.-R.S., Kim, J. A., Oh, J., & Kim, S. H. (2017). Translation and psychometric evaluation of a Korean version of the amyotrophic lateral sclerosis-specific quality of life-revised. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(1–2), 92–98.PubMed

30.

Mooij, R., Veldink, J. H., Van Den Berg, L. H., Maessen, M., Maille, R., Post, M. W., & Lindeman, E. (2007). Validity of the Dutch version of the amyotrophic lateral sclerosis assessment questionnaire, ALSAQ-40, ALSAQ-5. Amyotrophic Lateral Sclerosis, 8(2), 96–100.PubMed

31.

Felgoise, S. H., Feinberg, R., Stephens, H. E., Simmons, Z., Barkhaus, P., Boylan, K., Caress, J., Clawson, L. L., Elman, L., McCluskey, L. E. O., Goutman, S. A., Russell, J., Tiryaki, E., & Weiss, M. (2018). Amyotrophic lateral sclerosis-specific quality of life- short form (ALSSQOL-SF): A brief, reliable, and valid version of the ALSSQOL-R. Muscle and Nerve, 58(5), 646–654.PubMed

32.

Peseschkian, T., Schonfelder, E., Heinrich, F., Osmanovic, A., Petri, S., Schreiber-Katz, O., Cordts, I., Deschauer, M., Lingor, P., Gunther, R., Stolte, B., Hagenacker, T., Zeller, D., Schroter, C., Weyen, U., Regensburger, M., Wolf, J., Schneider, I., Hermann, A., … Boentert, M. (2021). A nation-wide, multi-center study on the quality of life of ALS patients in Germany. Brain Sciences, 11(3), 372.PubMedPubMedCentral

33.

Jenkinson, C. (1999). Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: The ALSAQ-40. Journal of Neurology, Supplement, 246(3), 16–21.

34.

Jenkinson, C., Fitzpatrick, R., Brennan, C., & Swash, M. (1999). Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(1), 33–40.PubMed

35.

Jenkinson, C., Levvy, G., Fitzpatrick, R., & Garratt, A. (2000). The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): Tests of data quality, score reliability and response rate in a survey of patients. Journal of the Neurological Sciences, 180(1–2), 94–100.PubMed

36.

Norquist, J. M., Fitzpatrick, R., & Jenkinson, C. (2004). Health-related quality of life in amyotrophic lateral sclerosis: Determining a meaningful deterioration. Quality of Life Research, 13(8), 1409–1414.PubMed

37.

Pavan, K., Marangoni, B. E. M., Zinezzi, M. O., Schmidt, K. B., Oliveira, B. C., Lianza, S., & Buainain, R. P. (2010). Validation of the amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40) scale in the Portuguese language. Arquivos de Neuro-Psiquiatria, 68(1), 48–51.PubMed

38.

Palmieri, A., Soraru, G., D’Ascenzo, C., Baggio, L., Ermani, M., Pegoraro, E., Angelini, C., & Lombardi, L. (2010). Quality of life and motor impairment in ALS: Italian validation of ALSAQ. Neurological Research, 32(1), 32–40.PubMed

39.

Salas, T., Mora, J., Esteban, J., Rodriguez, F., Diaz-Lobato, S., & Fajardo, M. (2008). Spanish adaptation of the amyotrophic lateral sclerosis questionnaire ALSAQ-40 for ALS patients. Amyotrophic Lateral Sclerosis, 9(3), 168–172.PubMed

40.

Shamshiri, H., Eshraghian, M. R., Ameli, N., & Nafissi, S. (2013). Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire. Iranian journal of neurology, 12(3), 102–105.PubMedPubMedCentral

41.

Felgoise, S. H., Bremer, B. A., Walsh, S. M., Hufford, D. J., Bromberg, M. B., David, W., Forshew, D. A., Heiman-Patterson, T. D., Lai, E. C., McCluskey, L., & Simmons, Z. (2006). The ALSSQOL: Balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology, 67(9), 1659–1664.PubMed

42.

Jenkinson, C., Peto, V., Hobart, J., Chandola, T., Fitzpatrick, R., & Swash, M. (2002). Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: Tests of data quality, score reliability, response rate and scaling assumptions. Journal of Neurology, 249(2), 178–183.PubMed

43.

Damiano, A. M., Patrick, D. L., Guzman, G. I., Gawel, M. J., Gelinas, D. F., Natter, H. M., & Ingalls, K. K. (1999). Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Medical care, 37(1), 15–26.PubMed

44.

Ruhland, J. L., Ross, M. A., Saehler, M. M., Smith, K. B., Heffner, M. L., & Shields, R. K. (1998). Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the tufts quantitative neuromuscular exam. Archives of Physical Medicine and Rehabilitation, 79(7), 855–862.PubMed

45.

Golab-Janowska, M., Honczarenko, K., & Stankiewicz, J. (2010). Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis. Neurologia i Neurochirurgia Polska, 44(6), 560–566.PubMed

46.

Jenkinson, C., & Fitzpatrick, R. (2001). Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: Development and validation of the ALSAQ-5. Journal of Neurology Neurosurgery and Psychiatry, 70(1), 70–73.PubMedPubMedCentral

47.

Jenkinson, C., Norquist, J. M., & Fitzpatrick, R. (2003). Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5). Journal of Neurology Neurosurgery and Psychiatry, 74(2), 242–245.PubMedPubMedCentral

48.

Jenkinson, C., Fitzpatrick, R., Swash, M., & Jones, G. (2007). Comparison of the 40-item amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey. Clinical Rehabilitation, 21(3), 266–272.PubMed

49.

Smith, P. S., Crossley, B., Greenberg, J., Wilder, C., & Carroll, B. (2000). Agreement among three quality of life measures in patients with ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(4), 269–275.PubMed

50.

Bromberg, M. B., Anderson, F., Davidson, M., & Miller, R. G. (2001). Assessing health status quality of life in ALS: Comparison of the SIP/ALS-19 with the ALS functional rating scale and the short form-12 health surveyTM. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2(1), 31–37.PubMed

51.

McGuire, D., Garrison, L., Armon, C., Barohn, R., Bryan, W., Miller, R., Parry, G., Petajan, J., & Ross, M. (1996). Relationship of the tufts quantitative neuromuscular exam (TQNE) and the sickness impact profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group. Neurology, 46(5), 1442–1444.PubMed

52.

Jenkinson, C., Fitzpatrick, R., Peto, V., & Swash, M. (2000). The ALS health profile study: Quality of life of amyotrophic lateral sclerosis patients and carers in Europe. Journal of Neurology, 247(11), 835–840.PubMed

53.

Epton, J., Harris, R., & Jenkinson, C. (2009). Quality of life in amyotrophic lateral sclerosis/motor neuron disease: A structured review. Amyotrophic Lateral Sclerosis, 10(1), 15–26.PubMed

54.

Hartmaier, S. L., Rhodes, T., Cook, S. F., Schlusser, C., Chen, C., Han, S., Zach, N., Murthy, V., & Davé, S. (2022). Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes. https://doi.org/10.1186/s12955-022-01919-9CrossRefPubMedPubMedCentral

55.

Kwok, E. Y. L., Rosenbaum, P., Thomas-Stonell, N., & Cunningham, B. J. (2021). Strengths and challenges of the COSMIN tools in outcome measures appraisal: A case example for speech-language therapy. International Journal of Language & Communication Disorders, 56(2), 313–329.

Titel: Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review
Auteurs: Faryal Zahir
Alicia Hanman
Nazmehr Yazdani
Sabrina La Rosa
Gemma Sleik
Brooke Sullivan
Ava Mehdipour
Selina Malouka
Ayse Kuspinar
Publicatiedatum: 07-03-2023
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 9/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-023-03377-2

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 9/2023

China Health Related Outcomes Measures (CHROME): development of a descriptive system to support cardiovascular disease specific preference-based measure for the Chinese population

Patients’ perspectives on irritable bowel syndrome: a qualitative analysis based on social media in China

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary

Health-state utilities in long-term advanced melanoma survivors comparable with the general population

Health-related quality of life 12 years after injury: prevalence and predictors of outcomes in a cohort of injured Māori

Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study